Victor Akpe

Dr. Victor Akpe

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in BMC Biotechnology
Verified
Journal Article
Open access
PDF file
TLThomas Liebmann
Thomas Liebmann
SRSusanna Rydholm
Susanna Rydholm
VAVictor Akpe
Victor Akpe
HBHjalmar Brismar
Hjalmar Brismar
Conventional cell culture studies have been performed on 2D surfaces, resulting in flat, extended cell growth. More relevant studies are desired to better mimic 3D in vivo tissue growth. Such realistic environments should be the aim of any cell growth study, requiring new methods for culturing cells in vitro. Cell biology is also tending toward miniaturization for increased efficiency and specificity. This paper discusses the application of a self-assembling peptide-derived hydrogel for use as a 3D cell culture scaffold at the microscale.

29 July 2020 in Journal of The Royal Society Interface
Verified
Journal Article
Closed access
VAVictor Akpe
Victor Akpe
TKTak Kim
Tak Kim
CBChristopher L. Brown
Christopher L. Brown
Ian Edwin CockIan Edwin Cock
Ian Edwin Cock
Circulating tumour cells (CTCs) have recently been identified as valuable biomarkers for diagnostic and prognostic evaluations, as well for monitoring therapeutic responses to treatments. CTCs are rare cells which may be present as one CTC surrounded by approximately 1 million white blood cells and 1 billion red blood cells per millilitre of peripheral blood. Despite the various challenges in CTC detection, considerable progress in detection methods have been documented in recent times, particularly for methodologies incorporating nanomaterial-based platforms and/or integrated microfluidics. Herein, we summarize the importance of CTCs as biological markers for tumour detection, highlight their mechanism of cellular invasion and discuss the various challenges associated with CTC research, including vulnerability, heterogeneity, phenotypicity and size differences. In addition, we describe nanomaterial agents used for electrochemistry and surface plasmon resonance applications, which have recently been used to selectively capture cancer cells and amplify signals for CTC detection. The intrinsic properties of nanomaterials have also recently been exploited to achieve photothermal destruction of cancer cells. This review describes recent advancements and future perspectives in the CTC field.

23 October 2025 in Journal of Nanotheranostics
Verified
Journal Article
Open access
PDF file
VAVictor Akpe
Victor Akpe
Ian Edwin CockIan Edwin Cock
Ian Edwin Cock
The integration of nanotheranostics into cancer treatment represents a transformative shift in oncology, combining precision diagnostics with targeted therapeutic interventions. This manuscript explores the advancements in nanotechnology-driven cancer therapies, highlighting the role of engineered nanoparticles, such as liposomes, dendrimers, polymeric micelles, and virus-like particles, in enhancing drug delivery, real-time imaging, and tumor-specific targeting. Additionally, emerging therapies, including immunotherapy, gene editing, and chromophore-assisted light inactivation (CALI), are discussed in the context of personalized medicine. The convergence of these strategies is poised to redefine cancer treatment paradigms, improving therapeutic efficacy while minimizing systemic toxicity. This review outlines the key challenges, current limitations, and future directions in nanotheranostic applications, emphasizing the need for interdisciplinary collaboration to optimize their clinical translation.

2 May 2014 in The Journal of Physical Chemistry C
Verified
Journal Article
Closed access
LLLi Li
Li Li
YCYun Chen
Yun Chen
GTGuangjun Tian
Guangjun Tian
VAVictor Akpe
Victor Akpe
HXHao Xu
Hao Xu
YFYing Fu
Ying Fu

24 June 2020 in Journal of The Royal Society Interface
Verified
Journal Article
Open access
VAVictor Akpe
Victor Akpe
MSMuhammad J. A. Shiddiky
Muhammad J. A. Shiddiky
TKTak Kim
Tak Kim
CBChristopher L. Brown
Christopher L. Brown
YYYusuke Yamauchi
Yusuke Yamauchi
Ian Edwin CockIan Edwin Cock
Ian Edwin Cock
Nanozymes are nanomaterials with intrinsic magnetism and superparamagnetic properties. In the presence of an external magnet, nanozyme particles aggregate and redisperse without a foreign attraction. We evaluated the performances of nanozyme by changing the biosensing platforms and substituting other biological variants for a complete cancer assay detection. We investigated the expression of morphological variants in the transmission of signals using an electrochemical method. The signal responses, including signal enhancement with the nanozyme (Au-Fe 2 O 3 ), showed a wide capturing range (greater than 80%, from 10 2 to 10 5 cells ml −1 in phosphate-buffered saline buffer, pH 7.4). The platform showed a fast response time within a dynamic range of 10–10 5 cells ml −1 for the investigated T47D cancer cell line. We also obtained higher responses for anti-HER2 (human epidermal receptor 2)/streptavidin interface as the biosensing electrode in the presence of T47D cancer cells. The positive assay produced a sixfold increase in current output compared to the negative target or negative biological variant. We calculated the limit of detection at 0.4 U ml −1 , and of quantitation at 4 U ml −1 (units per millilitre). However, blood volume amounts in clinical settings may constrain diagnosis and increase detection limit value significantly.